RanucciM,BaryshnikovaE,CastelvecchioS,PelisseroG, 2013.Major bleeding, transfusions, and anemia: the deadly triad of cardiac surgery,Ann Thorac Surg 96 478 -85
PetäjäJ,LundströmU,LeijalaM,PeltolaK,SiimesMA, 1995.Bleeding and use of blood products after heart operations in infants,J Thorac Cardiovasc Surg 109 524 -9
BronickiRA,HallM., 2016.Cardiopulmonary bypass-induced inflammatory response: pathophysiology and treatment,Pediatr Crit Care Med 17 S272 -S8
KraftF,SchmidtC,Van AkenH,ZarbockA, 2015.Inflammatory response and extracorporeal circulation,Best Pract Res Clin Anaesthesio 29 113 -23
SpiessBD, 2013.Blood transfusion and infection after cardiac surgery,Ann Thorac Surg 95 1855 -8
TempeDK,VirmaniS., 2002.Coagulation abnormalities in patients with cyanotic congenital heart disease,J Cardiothorac Vasc Anesth 16 752 -65
LaParDJ,CrosbyIK,AilawadiG,AdN,ChoiE,SpiessBD, 2013.Blood product conservation is associated with improved outcomes and reduced costs after cardiac surgery,J Thorac Cardiovasc Surg 145 796 -804
KerK,EdwardsP,PerelP,ShakurH,RobertsI, 2012.Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis,BMJ 344 e3054 -
LinCY,ShuhaiberJH,LoyolaH,LiuH,del NidoP,DiNardoJA, 2015.The safety and efficacy of antifibrinolytic therapy in neonatal cardiac surgery,PloS One 10 e0126514 -
OpotowskyAR,MokoLE,GinnsJ,RosenbaumM,GreutmannM,AboulhosnJ, 2015.Pheochromocytoma and paraganglioma in cyanotic congenital heart disease,J Clin Endocrinol Metab 100 1325 -34
ChauhanS,BisoiA,KumarN,MittalD,KaleS,KiranU, 2004.Dose comparison of tranexamic acid in pediatric cardiac surgery,Asian Cardiovasc Thorac Ann 12 121 -4
CouturierR,RubattiM,CredicoC,Louvain-QuintardV,AnerkianV,DoubineS, 2014.Continuous or discontinuous tranexamic acid effectively inhibits fibrinolysis in children undergoing cardiac surgery with cardiopulmonary bypass,Blood Coagul Fibrinolysis 25 259 -65
FaraoniD,CacheuxC,Van AelbrouckC,IckxBE,BarvaisL,LevyJH, 2014.Effect of two doses of tranexamic acid on fibrinolysis evaluated by thromboelastography during cardiac surgery: a randomised, controlled study,Eur J Anaesthesiol 31 491 -8
SigautS,TremeyB,OuattaraA,CouturierR,TaberletC,Grassin-DelyleS, 2014.Comparison of two doses of tranexamic acid in adults undergoing cardiac surgery with cardiopulmonary bypass,J Am Soc Anesthesiol 120 590 -600
PasqualiSK,LiJS,HeX,JacobsML,O'BrienSM,HallM, 2012.Comparative analysis of antifibrinolytic medications in pediatric heart surgery,J Thorac Cardiovasc Surg 143 550 -7
ReidRW,ZimmermanAA,LaussenPC,MayerJE,GorlinJB,BurrowsFA, 1997.The efficacy of tranexamic acid versus placebo in decreasing blood loss in pediatric patients undergoing repeat cardiac surgery,Anesth Analg 84 990 -6
SchindlerE,PhotiadisJ,SinzobahamvyaN,DöresA,AsfourB,HraskaV, 2011.Tranexamic acid: an alternative to aprotinin as antifibrinolytic therapy in pediatric congenital heart surgery,Eur J Cardiothorac Surg 39 495 -9
ChauhanS,BisoiA,ModiR,GhardeP,RajeshM., 2003.Tranexamic acid in paediatric cardiac surgery,Indian J Med Res 118 86 -
GiordanoR,PalmaG,PoliV,PalumboS,RussolilloV,CioffiS, 2012.Tranexamic acid therapy in pediatric cardiac surgery: a single-center study,Ann Thorac Surg 94 1302 -6
MartinK,BreuerT,GertlerR,HapfelmeierA,SchreiberC,LangeR, 2011.Tranexamic acid versus -aminocaproic acid: efficacy and safety in paediatric cardiac surgery,Eur J Cardiothorac Surg 39 892 -7
HasegawaT,OshimaY,MaruoA,MatsuhisaH,TanakaA,NodaR, 2014.Intraoperative tranexamic acid in pediatric bloodless cardiac surgery,Asian Cardiovasc Thorac Ann 22 1039 -45
PatelJ,PrajapatiM,PatelH,GandhiH,DeodharS,PandyaH. Topical, 2017.and low-dose intravenous tranexamic acid in cyanotic cardiac surgery,Asian Cardiovasc Thorac Ann 25 118 -22
NgWCK,JerathA,WasowiczM., 2015.Tranexamic acid: a clinical review,Anaesthesiol Intensive Ther 47 339 -50